Clinical study - Recherches "plusieurs pathologies"
EXPRESS
Recherches "plusieurs pathologies"
Essai clinique fermé
Public cible
Adulte
Low level of genomic alteration to predict exceptional and unexpected response to targeted thÚrapies in patients with solid tumors.;EXPRESS : EXcePtional RESponSe
Description de l'essai
The EXPRESS study involves patients who experienced exceptional efficacy of targeted therapy, much more than expected. The objective is to analyze the tumor itself in order to understand this exceptional efficacy. The is no direct benefit for participating patients. Now, results might be of help for other patients.
Liens utiles
CHRISTOPHE LE TOURNEAU
Investigateur principal